Evidence map›Paper›PMID 28444710›Full record

ReviewNeurourology and urodynamics2017

Can we define and characterize the aging lower urinary tract?-ICI-RS 2015.

Bahareh Vahabi, Adrian S Wagg, Peter F W M Rosier, Kevin L J Rademakers, Marie-Astrid Denys, Michel Pontari, Thelma Lovick, Francoise A Valentini, Pierre P Nelson, Karl-Erik Andersson and 1 more

Abstract readReview
In one paragraph

Review in Neurourology and urodynamics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Functional brain imaging in voiding dysfunction.Current bladder dysfunction reports · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bahareh VahabiDepartment of Biological, Biomedical and Analytical Sciences, University of the West of England, Bristol, United Kingdom.
Adrian S WaggDivision of Geriatric Medicine, University of Alberta, Edmonton, Alberta, Canada.
Peter F W M RosierDepartment of Urology, University Medical Center, Utrecht, The Netherlands.
Kevin L J RademakersDepartment of Urology, University of Maastricht, Maastricht, The Netherlands.
Marie-Astrid DenysDepartment of Urology, Ghent University Hospital, Ghent, Belgium.
Michel PontariDepartment of Urology, Temple University, Pennsylvania.
Thelma LovickSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom.
Francoise A ValentiniER6-Universite Pierre et Marie Curie (Paris 06), Paris, France.
Pierre P NelsonER6-Universite Pierre et Marie Curie (Paris 06), Paris, France.
Karl-Erik AnderssonInstitute of Advanced Studies, University of Aarhus, Aarhus, Denmark.
Christopher H FrySchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom.

Funding

PDE5 Inhibition of Afferents and Interstitial Cells in Overactive Mouse BladdersR01DK098361 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BIRDER, LORI A, KANAI, ANTHONY JOHN · 2014 to 2024
$5.7M
NIDDK NIH HHS R01 DK098361
6 · The paper itself

Abstract

The prevalence of lower urinary tract (LUT) symptoms increases with age but the etiology is unknown. This article aims to identify research directions that clarify the basis of this association. The initial question is whether biological age is the variable of interest or a time-dependent accumulation of factors that impact on LUT function at rates that differ between individuals. In particular, the accumulation of conditions or agents due to inflammatory states or tissue ischemia is important. Much of the above has been concerned with changes to bladder function and morphology. However, the outflow tract function is also affected, in particular changes to the function of external sphincter skeletal muscle and associated sacral motor nerve control. Nocturia is a cardinal symptom of LUT dysfunction and is more prevalent with aging. Urine production is determined by diurnal changes to the production of certain hormones as well as arterial blood pressure and such diurnal rhythms are blunted in subjects with nocturia, but the causal links remain to be elucidated. Changes to the central nervous control of LUT function with age are also increasingly recognized, whether in mid-brain/brainstem regions that directly affect LUT function or in higher centers that determine psycho-social and emotional factors impinging on the LUT. In particular, the linkage between increasing white matter hyperintensities and LUT dysfunction during aging is recognized but not understood. Overall, a more rational approach is being developed to link LUT dysfunction with factors that accumulate with age, however, the precise causal pathways remain to be characterized. Neurourol. Urodynam. 36:854-858, 2017. © 2017 Wiley Periodicals, Inc.

Indexed as

AgingAnimalsHumansLower Urinary Tract SymptomsModels, BiologicalNocturiaUrinary Bladder DiseasesUrinary Tractagingbladdercentral nervous systemischemialower urinary tract symptomsoutflow tract

Identifiers

PMID28444710
PMCPMC5556389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.